Records containing: Progressive Familial Intrahepatic Cholestasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-02Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
-
CLINICAL_TRIALS study record update · 2026-04-01Registry to Document Treatment Effectiveness, Safety, Including Prospective Long-term Outcomes in Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay)
-
CLINICAL_TRIALS study record update · 2026-03-27DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE
-
CLINICAL_TRIALS study record update · 2025-08-12Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
-
CLINICAL_TRIALS study record update · 2025-07-10An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children With Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-25Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
-
CLINICAL_TRIALS study record update · 2025-02-06Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
-
CLINICAL_TRIALS study record update · 2025-01-24Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)
-
CLINICAL_TRIALS study record update · 2025-01-17Genotype-phenotype Relationship Between Adult Cryptogenic Cholestasis and Mutations in Genes Responsible for Progressive Familial Intrahepatic Cholestasis
-
CLINICAL_TRIALS study record update · 2025-01-17NAtural Course and Prognosis of PFIC and Effect of Biliary Diversion (NAPPED Study), Meta-analysis of Individual Patient Data of PFIC Before and After Surgery (Bile Diversion or Liver Transplantation)
-
CLINICAL_TRIALS study record update · 2024-03-21Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry
-
CLINICAL_TRIALS study record update · 2024-03-07An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-A4250 in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2024-03-07A Phase I, Double-Blind Single and Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of A4250 as Monotherapy, and in Combination With Colonic Release Cholestyramine (A3384) or Commercially Available Cholestyramine (Questran™) in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-03-07Odevixibat (A4250) for the Treatment of Progressive Familial Intrahepatic Cholestasis (Expanded Access Program)
-
CLINICAL_TRIALS study record update · 2020-08-24Gastrostomy-Biliary Diversion: Innovative Management for Children With Bile Canalicular Transport Disorders
-
CLINICAL_TRIALS study record update · 2019-03-18Validation of the ItchRO Diaries in Pediatric Cholestatic Liver Disease